The Medical Letter. on Drugs and Therapeutics

Similar documents
Comparison of representative topical corticosteroid preparations (classified according to the US system)

Quarterly pharmacy formulary change notice

Pharmacy Benefit Determination Policy

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Drug Class Literature Scan: Topical Steroids

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Comparison of representative topical corticosteroid preparations (classified according to the US system)

Eucrisa. Eucrisa (crisaborole) Description

Eucrisa. Eucrisa (crisaborole) Description

Effective for all members on August 1, 2017

Michigan Pharmacy and Therapeutics Committee September 9, 2014 at 6:00 PM Kellogg Center, East Lansing, Michigan

The safety and effectiveness of Dupixent in pediatric patients have not been established (1).

See Important Reminder at the end of this policy for important regulatory and legal information.

Dupixent (dupilumab)

Children s Hospital Of Wisconsin

Pharmacologic Treatment of Atopic Dermatitis

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August

See Important Reminder at the end of this policy for important regulatory and legal information.

The Medical Letter. on Drugs and Therapeutics. Drug Some Formulations OTC/Rx Usual Dosage Comments Class Comments Cost 1

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)

Connecticut Medicaid P&T Meeting Minutes December 2, 2010

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

2015 Medicare Step Therapy Criteria. Last Modified: 12/31/2014 Last Submitted to CMS: 10/29/2014

Topical Immunomodulators

Clinical pharmacology review for primary health care providers: II. Steroids

Clinical Policy: Dupilumab (Dupixent) Reference Number: ERX.SPA.49 Effective Date:

Step Therapy Medications

High-Cost Drug Exclusions

2014 Medicare Step Therapy Criteria. Last Modified: Last Submitted to CMS:

84:00. Skin and Mucous Membrane Agents. 84:00 Skin and Mucous Membrane Agents

ALLERGIC RHINITIS-NASAL

High-Cost Drug Exclusions

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

See Important Reminder at the end of this policy for important regulatory and legal information.

Literature Scan: Topical Corticosteroids. Month/Year of Review: March 2015 Date of Last Review: March 2013 Source Document: OSU College of Pharmacy

2018 Step Therapy (ST) Criteria

Step Therapy Criteria 2019

Managing and Minimizing Flare-ups in Atopic Dermatitis

Topical Products with Quantity Limits

High-Cost Drug Exclusions

Calgary Zone LTC Formulary Autosubstitution List

Calgary Zone LTC Formulary Autosubstitution List

DECISION PAPER DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS August 2013

15 minute eczema consultation

BB&T 2014 Step Therapy Program Drug List

79 C. Michael Davenport Blvd. Suite A Frankfort, KY August 5, Dear Kentucky Medicaid Provider:

Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)

Medication Quick Reference

NHA Automatic Therapeutic Interchange Policy (Updated July 23, 2015)*

Select Drug Quantity Management

Category Second-Line (Targeted) First-Line (Alternative) Most Common Indication

2019 PacificSource Health Plans Step Therapy Criteria. Last Modified: 02/22/2019 (All criteria reviewed at least once per year)

LABEL NAME CHANGE EFFECTIVE DATE ARCALYST 220 MG INJECTION

Drug Allergy: A Rash ionale for Treatment

Topical Corticosteroids

2017 Step Therapy (ST) Criteria

Relative Efficacy and Interchangeability of Various Clobetasol Propionate Vehicles in the Management of Steroid-Responsive Dermatoses

NEW PRODUCTS: HAILEY TM 24 Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 1 mg/20

Skin Manifestations of Allergy

Pharmacy Updates Summary

Using Your ESP* in Pharmacy: How to Improve Treatment Adherence and Patient Outcomes in Psoriasis (*Expanded Scope of Practice)

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

Drug Formulary Update, April 2017 Commercial and State Programs

ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS

ADDITIONAL 2017 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS

ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP

BlueLink TPA FlexRx Updates

CHANGES TO YOUR DRUG LIST

Below is a summary of the PDL changes that will be effective May 1, All other agents in these classes will retain their current PDL listing.

The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3

Designing a Campaign On Topical steroids misuse

2018 Step Therapy (ST) Criteria

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE. Final Appraisal Determination. Frequency of application of topical corticosteroids for atopic eczema

DRUG SCHEDULES REGULATION CHANGES JUNE 2018

(12) Patent Application Publication (10) Pub. No.: US 2012/ A1

International Journal of Scientific & Engineering Research Volume 9, Issue 8, August ISSN

New Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003

Product List Finished Dosage Forms (FDF) B2B Business

PRODUCT MONOGRAPH. Taro-Mometasone Cream (Mometasone Furoate Cream, USP) 0.1% (w/w)

MEDICAL ASSISTANCE BULLETIN

2018 PacificSource Health Plans Step Therapy Criteria. Last Modified: 5/22/2018 (All criteria reviewed at least once per year)

(12) United States Patent

DUPIXENT (dupilumab) subcutaneous injection

Prior Authorization Topical Immunomodulators Elidel and Protopic 0.03%

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

3. Acyclovir 5% ointment with Dyclonine HCl 1% or Lidocaine 1% Compound Sig: Apply to affected area q2h (start applying prodromal stage)

Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities

PRODUCT MONOGRAPH ELOCOM. Mometasone Furoate Cream, BP, 0.1% Mometasone Furoate Ointment, Merck Standard, 0.1% Mometasone Furoate Lotion, 0.

Symbiotica Speciality Ingredients Sdn. Bhd. Malaysia

The active ingredient of any pharmaceutical

Topical Agents Available Strengths. Fml Limits 0.05% NF $ % QL % ST % - $ % ST; QL % QL $ % NF $67.

Patient reported outcomes in chronic skin diseases: ehealth applications for clinical practice van Cranenburgh, O.D.

The Medical Letter. on Drugs and Therapeutics

2017 Formulary Changes Year to Date

See Important Reminder at the end of this policy for important regulatory and legal information.

Transcription:

The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call: 800-211-2769 Last updated: April 27, 2017 Comparison Table: Some Topical Corticosteroids The Medical Letter on Drugs and Therapeutics Comparison Table: Some Topical Corticosteroids 1,2 Super-High Potency Betamethasone dipropionate augmented generic Apply once/d or bid Should only be used short-term $105.70 (15 g x 2) Diprolene (Merck) Clobetasol propionate generic Clobex (Galderma) gel foam spray shampoo Apply once/d Should not be used under occlusion Ointments are generally the most effective formulations Foams and sprays can be applied to large areas, but the alcohol base used in many of them may cause burning Foam: dispense small amount onto a saucer or other cool surface; will melt immediately if dispensed onto hands 170.70 (15 g x 2) 124.50 (30 g) 158.40 (30 g) 222.35 (30 g) 136.50 (50 ml) 149.00 (60 ml) 292.30 (50 g) 329.10 (59 ml) 303.60 (118 ml) 500.10 (60 ml) spray 442.50 (59 ml) shampoo Apply once/d 837.80 (118mL) Olux (Prestium/Mylan) foam 493.00 (50 g) Olux-E (Mylan) foam 493.00 (50 g) Temovate (Fougera) 264.10 (30 g) 267.50 (30 g) Cormax (Hi Tech) 36.00 (50 ml) Fluocinonide generic 0.1% Apply once/d 323.80 (30 g) Vanos (Valeant) 952.30 (30 g) Halobetasol propionate generic Apply once/d or bid 153.10 (50 g) 178.10 (50 g) Ultravate (Ranbaxy) 916.00 (50 g) 916.00 (50 g) 916.00 (60 ml) e91

High Potency Amcinonide generic 0.1% or tid Should only be used short-term Betamethasone dipropionate augmented Apply once/d or bid generic $324.00 (60 g) 42.50 (15 g x 2) Diprolene AF (Merck) Betamethasone dipropionate generic Desoximetasone generic Topicort (Taro) 0.25% Apply once/d or bid 170.70 (15 g x 2) 87.00 (45 g) 199.20 (60 g) 214.50 (60 g) 343.80 (60 g) 343.60 (60 g) Desoximetasone generic gel 147.00 (15 g x 2) Diflorasone diacetate generic Apply 1-3 times/d 335.50 (30 g) Fluocinonide generic Apply 2-4 times/d 111.20 (30 g) gel 95.30 (30 g) 72.90 (30 g) 81.00 (60 ml) Halcinonide Halog (Ranbaxy) 0.1% -tid 452.80 (30 g) 452.80 (30 g) Mometasone furoate generic 0.1% Apply once/d 32.00 (15 g x 2) Elocon (MSD) 109.50 (15 g x 2) Medium-High Potency Amcinonide generic 0.1% or tid 189.00 (30 g) Betamethasone dipropionate generic Betamethasone valerate generic Desoximetasone generic 0.1% Apply once/d or bid Apply 1-3 times/d 271.40 (60 ml) 84.50 (15 g x 2) 32.50 (15 g x 2) 35.40 (15 g x 2) 87.40 (15 g x 2) Diflorasone diacetate generic Apply 1-3 times/d 335.50 (30 g) Fluocinonide emollient generic Apply 2-4 times/d 77.10 (30 g) Fluticasone propionate generic 0.005% 57.20 (30 g) Triamcinolone acetonide generic 0.5% Apply 2-4 times/d 16.40 (15 g x 2) or tid 17.39 (15 g x 2) e92

Medium Potency Betamethasone dipropionate spray Sernivo: shake well before use Sernivo (Promius) Luxiq: dispense small amount onto a saucer or other cool surface; foam $780.00 (120 ml) Betamethasone valerate generic 0.12% foam will melt immediately if dispensed onto hands 261.50 (50 g) Luxiq (Prestium/Mylan) 411.60 (50 g) Fluocinolone acetonide generic 0.025% Apply 3-4 times/d 57.10 (15 g x 2) Synalar (Medimetriks) Apply 2-4 times/d 409.25 (120 g) Flurandrenolide generic or tid 523.00 (60 g) Cordran (Aqua) 581.00 (60 g) Hydrocortisone valerate generic 0.2% or tid 157.40 (15 g x 2 ) Mometasone furoate generic 0.1% Apply once/d 35.00 (15 g x 2) Elocon (MSD) 109.50 (15 g x 2) Triamcinolone acetonide generic 0.1% or tid 6.00 (30 g) 6.20 (30 g) Triderm (Crown) 355.00 (30 g) Triamcinolone acetonide Trianex (Promius) Apply 2-4 times/d 860.00 (430 g) Medium-Low Potency Betamethasone dipropionate generic 38.50 (60 ml) Betamethasone valerate generic 0.1% Apply 1-3 times/d 35.50 (15 g x 2) Desonide generic Apply 2-4 times/d 96.20 (15 g x 2) Fluocinolone acetonide generic 0.025% Apply 2-4 times/d 58.50 (15 g x 2) Synalar (Medimetriks) 409.30 (120 g) Flurandrenolide generic or tid 825.30 (120 g) 825.30 (120 ml) Cordran (Aqua) 962.00 (120 g) 962.00 (120 ml) Fluticasone propionate generic Apply once/d or bid 25.80 (30 g) Apply once/d 665.70 (120 ml) Cutivate (PharmaDerm) Apply once/d or bid 113.10 (30 g) Apply once/d 1068.80 (120 ml) e93

Medium-Low Potency (continued) Hydrocortisone butyrate generic 0.1% or tid $100.20 (15 g x 2) 95.50 (15 g x 2) 191.20 (60 ml) Locoid (Onset) 218.50 (15 g x 2) 206.30 (15 g x 2) 416.50 (60 ml) Locoid Lipo 150.10 (15 g x 2) Hydrocortisone probutate Pandel (Sandoz) 0.1% Apply once/d or bid 984.10 (80 g) Hydrocortisone valerate generic 0.2% or tid 143.30 (15 g x 2) Prednicarbate generic 0.1% 114.30 (60 g) 61.50 (60 g) Dermatop (Valeant) 133.40 (60 g) 110.50 (60 g) Triamcinolone acetonide generic 0.025% Apply 2-4 times/d 10.00 (15 g x 2) Triamcinolone acetonide generic 0.1% Apply 3-4 times/d 29.00 (60 ml) Low Potency Alclometasone dipropionate generic -tid 90.50 (60 g) 73.90 (60 g) Betamethasone valerate generic 0.1% Verdeso should be dispensed by inverting can; upright actuation may cause incorrect dosage delivery 60.00 (60 ml) Clocortolone pivalate generic 0.1% Apply tid 268.70 (45 g) Cloderm (Promius) 325.50 (45 g) Desonide generic 128.50 (30 g) 236.90 (60 ml) Desowen (Galderma) 516.70 (60 g) 334.40 (60 ml) Desonate (Bayer) gel 513.40 (60 g) Verdeso (Stiefel) foam 780.00 (100 g) Fluocinolone acetonide generic 0.01% Apply 2-4 times/d 111.40 (60 g) 125.30 (60 ml) Triamcinolone acetonide generic 0.025% Apply 2-4 times/d 7.20 (30 g) 29.00 (60 ml) e94

Lowest Potency Hydrocortisone generic Hydrocortisone generic 2.5% 1.0% -qid Apply up to tid-qid Hydrocortisone 2.5% is available by prescription only Hydrocortisone 1% and 0.5% are available without a prescription Individual retailers may have their own OTC generic products May be ineffective for some indications $2.70 (20 g) 3.00 (30 g) 16.40 (60 ml) 6.80 (30 g) 4 Safe for use on the face and intertriginous areas 6.80 (30 g) 4 Aquanil-HC (Person & Covey) 8.00 (120 ml) 4 Hydrocortisone generic 0.5% Apply up to tid-qid 3.30 (30 g) 5.00 (30 g) 4 Nu-Derm Tolereen (Obagi) 0.5% 27.00 (57 g) 1. Drugs for psoriasis. Med Lett Drugs Ther 2015; 57:81. 2. Drugs for allergic disorders. Med Lett Drugs Ther 2017; 59:71. 3. Approximate WAC for smallest available package size. WAC = wholesaler acquisition cost or manufacturer s published price to wholesalers; WAC represents a published catalogue or list price and may not represent an actual transactional price. Source: AnalySource Monthly. April 5, 2017. Reprinted with permission by First Databank, Inc. All rights reserved. 2017 www.fdbhealth.com/policies/drug-pricing-policy. 4. Price according to walgreens.com. Accessed April 27, 2017.